<DOC>
	<DOCNO>NCT01299103</DOCNO>
	<brief_summary>The study enroll treat patient assess improvement appearance facial wrinkle .</brief_summary>
	<brief_title>Safety Efficacy Single Therapy Versus Double Triple Therapy Pellevé™ Wrinkle Treatment System Treatment Moderate Facial Wrinkles</brief_title>
	<detailed_description>The study enroll treat total 44 subject ( 23 treatment Group A receive single treatment 21 treatment Group B receive two treatment ) moderate facial wrinkle correspond grade 4-6 validate Fitzpatrick Wrinkle Assessment Scale .</detailed_description>
	<mesh_term>Facies</mesh_term>
	<criteria>Females 3560 year age Fitzpatrick Skin Color Type IIV . Subjects clinical evidence facial wrinkle mild moderate severity specify grade 46 Fitzpatrick Wrinkle Assessment Scale . Willingness ability comply protocol requirement , include return followup visit abstain exclusionary procedure duration study . Willingness ability provide write photo consent adherence photography procedure ( i.e. , removal jewelry makeup ) . Willingness ability provide write informed consent prior performance study related procedure . Subjects pregnant , nursing , plan become pregnant , and/or use reliable form birth control . Subjects prior exposure hyaluronic acid , filler , injection purpose 12 month precede study enrollment duration study . Subjects prior exposure botulinum toxin facial rhytids 6 month precede study enrollment duration study . Subjects prior cosmetic procedure improve facial rhytids ( i.e. , rhytidectomy , periorbital eyelid/eyebrow surgery , brow lift , CO2/erbium laser resurfacing , Thermage/Thermacool radiofrequency treatment ) within 12 month visible scar may affect evaluation response and/or quality photography . Ablative skin resurface glabellar area within previous 6 month study . Retinoid , microdermabrasion , prescription level glycolic acid treatment within 3 month prior study participation study . Active cut , wound , infection skin . Oral Isotretinon within past 12 month . Active HSV1 . History keloid hypertrophic scar . Existing history skin malignancy . Any exist skin disease . History collagen vascular disease . Subjects implantable pacemaker , automatic implantable defibrillator/ cadioversor ( AICD ) , implantable electric device . Subjects use , within 30 day , medication cause dermal hypersensitivity affect skin characteristic . History autoimmune disease . History disease inhibits pain sensation . History Diabetes I II . Concurrent therapy , investigator 's opinion , would interfere evaluation safety efficacy study medication . Subjects anticipate need surgery overnight hospitalization study . Subjects , Investigator 's opinion , history poor cooperation , non¬compliance medical treatment unreliability . Enrollment active study involve use investigational device drug .</criteria>
	<gender>Female</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>wrinkle</keyword>
	<keyword>rhytide</keyword>
</DOC>